Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

FDA Arthritis Advisory Committee meets to review Aslera NDA

April 20, 2001

Hydroxamic acid-based compounds described by American Cyanamid as TNF-alpha/MMP inhibitors

April 18, 2001

FDA issues approvable letter for Celebrex revised labeling

April 18, 2001

Recent patent describes Molecumetics' reverse-turn mimetics and their use

April 17, 2001

Second-generation antisense drug shows promise in phase I

April 17, 2001

Oral formulation of Isis antisense drug enters clinical evaluation

April 12, 2001

FDA issues approvable letter for changes to Vioxx labeling

April 11, 2001

Dose-dependent response reported by La Jolla for LJP-394 at recent lupus conference

April 10, 2001

Canadian-Japanese team discovers new cytokine inhibitors

April 9, 2001

Pfizer reports hydroxamic acid-based selective aggrecanase inhibitors

April 9, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Wuxi Apptec insists it’s ‘not a Chinese military company’
BioWorld
Wuxi Apptec isn’t going down without a fight after the U.S. Department of Defense added it to the Section 1260H list June 8 as a designated “Chinese military...
Antares Therapeutics divulges new CDK2/cyclin E1 inhibitors
BioWorld Science
Antares Therapeutics Inc. has reported new CDK2/cyclin E1 inhibitors potentially useful for the treatment of cancer.